|
|
||||||||
From the Departments of Neurology (Drs. Postma, Verstappen, Scheltens, and Heimans), Medical Psychology (Drs. Klein, van der Ploeg, and Aaronson), and Radiation Oncology (Drs. Langendijk and Slotman), Vrije Universiteit Medical Center, Amsterdam; Department of Neurology (Drs. Bromberg, Swennen, and Taphoorn), University Medical Center, Utrecht; Department of Psychosocial Research and Epidemiology (Dr. Aaronson), The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Address correspondence and reprint requests to T.J. Postma, MD, Dept. of Neurology, Vrije Universiteit Medical Center, P.O. Box 7057, 1007 MB Amsterdam, the Netherlands; e-mail: TJ.Postma{at}vumc.nl
Abnormalities on CT or MRI and neuropsychological performance in patients with low-grade glioma, with (n = 23) or without (n = 16) prior cerebral radiotherapy, were evaluated. Cerebral atrophy was observed in 14 of 23 patients (61%) treated with prior radiotherapy, and in 1 of 16 patients (6%) without prior radiotherapy. White matter abnormalities were observed in six patients, all of whom were treated with prior radiotherapy. These radiologic cerebral abnormalities correlated with cognitive performance.
This article has been cited by other articles:
![]() |
Y. Cao, C. I. Tsien, P. C. Sundgren, V. Nagesh, D. Normolle, H. Buchtel, L. Junck, and T. S. Lawrence Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for Prediction of Radiation-Induced Neurocognitive Dysfunction Clin. Cancer Res., March 1, 2009; 15(5): 1747 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J.B. Taphoorn Neurocognitive Effects of Radiotherapy ASCO Educational Book, January 1, 2009; 2009(1): 90 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Correa and L. E. Abrey Imaging Neurotoxicity: Is a Picture Worth a Thousand Words? AJNR Am. J. Neuroradiol., February 1, 2005; 26(2): 205 - 206. [Full Text] [PDF] |
||||
![]() |
C. S. Wong and A. J. Van der Kogel MECHANISMS OF RADIATION INJURY TO THE CENTRAL NERVOUS SYSTEM: IMPLICATIONS FOR NEUROPROTECTION Mol. Interv., October 1, 2004; 4(5): 273 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Klein and J. J. Heimans The Measurement of Cognitive Functioning in Low-Grade Glioma Patients After Radiotherapy J. Clin. Oncol., March 1, 2004; 22(5): 966 - 967. [Full Text] [PDF] |
||||
![]() |
D. D. Correa, L. M. DeAngelis, W. Shi, H. Thaler, A. Glass, and L. E. Abrey Cognitive functions in survivors of primary central nervous system lymphoma Neurology, February 24, 2004; 62(4): 548 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pace, A. Vidiri, E. Galie, M. Carosi, S. Telera, A. M. Cianciulli, P. Canalini, D. Giannarelli, B. Jandolo, and C. M. Carapella Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response Ann. Onc., December 1, 2003; 14(12): 1722 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Packer and M. Mehta Neurocognitive sequelae of cancer treatment Neurology, July 9, 2002; 59(1): 8 - 10. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |